Last but not least, all the regulatory enzymes discovered in this study, including USP34, Pin1, Plk1, CDK1 and Ubc9, could be effective drug targets for combination therapies to treat GBMs and potentially other malignant tumors. The gene discussed is PLK1; the disease is cancer.